Levoprint

Levoprot is an antitussive drug.

[1]

Indications Levoprom

It is used for the treatment of symptoms of non-productive dry cough that occurs with various diseases:

• laryngitis, asthma, or pharyngitis;
• bronchopneumonia, pulmonary emphysema or chronic obstructive bronchitis;
• influenza, tracheobronchitis or tracheitis of an acute nature;
• diseases affecting respiratory ducts, and having an infectious-inflammatory or allergic origin.

[2],

Release form

Release of the medicine is made in the form of a syrup, in glass bottles, having a capacity of 60 or 120 ml. Inside the box there is one such bottle, to which a measuring cup is attached.

[3]

Pharmacodynamics

Levoprot is an antitussive drug that has a predominantly peripheral effect. It inhibits the release of histamine with neuropeptides (substance type P, etc.), and at the same time it weakens the frequency and severity of cough.

In addition to these properties also has broncholytic activity.

[4], [5]

Dosing and administration

Take the syrup is necessary orally - for adolescents over 12 years of age and adults, the dosage is 60 mg, with a 3-fold use per day (intervals between doses - 6 hours).

Children under the age of 12 should drink syrup 3 times a day in a dose of 1 mg / kg.

[8]

Use Levoprom during pregnancy

Do not use the drug with lactation or pregnancy.

Contraindications

The main contraindications:

• increased sputum excretion;
• weakening of mucociliary activity;
• problems in the work of the liver, which have a pronounced character;
• the presence of intolerance against levorropropyzin.

Caution is required when using in people with insufficient renal activity to a severe degree. In addition, the medicine is prescribed with caution and diabetics, because the syrup contains 3.5 g of sucrose.

Side effects Levoprom

The intake of syrup can lead to the development of some side effects:

• disorders affecting the digestive function: vomiting, diarrhea, abdominal discomfort, nausea and heartburn;
• problems in the work of the peripheral system and the central nervous system: fainting, headaches, fatigue or drowsiness, dizziness, paresthesia and blurred vision;
• manifestations of the epidermis: itching or rashes;
• disorders of SSS: development of tachycardia.

[6], [7]

Interactions with other drugs

Combined use of Levoprot with drugs that have a sedative effect can lead to a potentiation of the inhibitory effect on the CNS.

[9]

Storage conditions

Levoprotte should be stored in a place that is closed from penetration of children. Temperature values are standard for medication maintenance.

Shelf life

Levoprot may be used within 24 months of the manufacture of the therapeutic drug.

Analogues

The analogues of the medication are Broncholitin, Sinekod and Broncholitin tablets with Pakeladin, and in addition Glauvent, Privitus, Libeksin with Panathus forte and Rapitus.

[10], [11]